,
,
Sexual dysfunction in patients with spinal cord lesions, Handb Clin Neurol, vol.130, pp.225-270, 2015. ,
Global incidence and prevalence of traumatic spinal cord injury, Can J Neurol Sci J Can Sci Neurol. juill, vol.40, issue.4, pp.456-64, 2013. ,
prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord, janv, vol.44, issue.3, pp.523-532, 2006. ,
Long-term effects of spinal cord injury on sexual function in men: implications for neuroplasticity. Spinal Cord, vol.45, pp.338-386, 2006. ,
Targeting recovery: priorities of the spinal cord-injured population, J Neurotrauma. oct, vol.21, issue.10, pp.1371-83, 2004. ,
Treating Erectile Dysfunction and Central Neurological Diseases with Oral Phosphodiesterase Type 5 ,
Review of the Literature, J Sex Med. avr, vol.9, issue.4, pp.970-85, 2012. ,
,
, , vol.164, pp.4764-4772, 2002.
Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review, Urology. sept ,
Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients, Eur Urol. août, vol.38, issue.2, pp.184-93, 2000. ,
Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction, Spinal Cord. juin, vol.38, issue.6, pp.363-70, 2000. ,
A twopart pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury, Spinal Cord. févr, vol.37, issue.2, pp.110-116, 1999. ,
,
, Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury
, Sildenafil Study Group. Ann Neurol. juill, vol.46, issue.1, pp.15-21, 1999.
Efficacy and safety of phosphodieterase-5 inhibitors for treatment of erectile dysfunction secondary to spinal cord injury: a systemic review and meta-analysis, Spinal Cord. juill, vol.54, issue.7, pp.494-501, 2016. ,
Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men, Spinal Cord. févr, vol.45, issue.2, pp.169-73, 2007. ,
, Sexual Activity in Spinal Cord Injured Men and Women | SCIRE Project
rehabilitationevidence/sexual-health/sexual-activity-in-spinal-cord-injured-men-and-women 16 ,
, Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries, Int J Androl. 1 déc, vol.33, issue.6, pp.861-865, 2010.
Rehabilitation of spinal cord injury in France: a nationwide multicentre study of incidence and regional disparities, Spinal Cord, vol.43, issue.6, pp.357-65, 2005. ,
Sexual dysfunction in patients with spinal cord lesions, Handb Clin Neurol, vol.130, pp.225-270, 2015. ,
Global incidence and prevalence of traumatic spinal cord injury, Can J Neurol Sci, vol.40, issue.4, pp.456-64, 2013. ,
prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord, vol.44, pp.523-532, 2006. ,
Long-term effects of spinal cord injury on sexual function in men: implications for neuroplasticity, Spinal Cord, vol.45, issue.5, pp.338-386, 2006. ,
Réactions sexuelles et orgasme chez le patient traumatisé médullaire : un modèle de rééducation/réadaptation ,
, avril, vol.18, issue.2, pp.114-134, 2009.
Sexual function in a traumatic spinal cord injured population 10â?-45 years after injury, Journal of Rehabilitation Medicine, vol.44, issue.11, pp.926-957, 2012. ,
Impact of spinal cord injury on sexuality: broad-based clinical practice intervention and practical application, J Spinal Cord Med, vol.35, issue.4, pp.211-219, 2012. ,
, NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA, vol.270, pp.83-90, 1993.
Targeting recovery: priorities of the spinal cord-injured population, J Neurotrauma, vol.21, issue.10, pp.1371-83, 2004. ,
Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal Cord, 2007. ,
Clinical efficacy and safety of Vitaros©/Virirec© (Alprostadil cream) for the treatment of erectile dysfunction, Rivista Urologia, vol.82, issue.2, pp.84-92, 2015. ,
Actes des 25ème Entretiens annuels de la Fondation Garches-Les troubles urinaires et sexuels du patient neurologique, 2012. ,
Mise au point : insuffisance érectile. Association Française d'Urologie ,
Rééducation et Réadaptation du patient blessé médullaire. Cofemer, 2011. ,
Sexual function in spinal cord injury men. I. Assessing sexual capability, Paraplegia, vol.31, issue.12, pp.771-84, 1993. ,
The Effects of Spinal Cord Injury on Psychogenic Sexual Arousal in Males, The Journal of Urology, 2007. ,
Atlas d'Anatomie Humaine, pp.388-389 ,
,
, Neuroanatomy and neurophysiology related to sexual dysfunction in male neurogenic patients with lesions to the spinal cord or peripheral nerves, Spinal Cord, vol.48, issue.3, pp.182-91, 2010.
Modulation of Soluble Guanylate Cyclase for the Treatment of Erectile Dysfunction, Physiology, vol.28, issue.4, pp.262-271, 2013. ,
The interaction of the penetration enhancer DDAIP with a phospholipid model membrane, Int J Pharm, vol.271, issue.1-2, pp.5-10, 2004. ,
Topical alprostadil cream for the treatment of erectile dysfunction, Expert Opin Pharmacother, vol.5, issue.3, pp.623-655, 2004. ,
Retention and migration of alprostadil cream applied topically to the glans meatus for erectile dysfunction, Int J Impot Res, vol.17, issue.1, pp.91-96, 2004. ,
The efficacy and safety of a topical alprostadil cream, Alprox-TD®, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED, Int J Impot Res, vol.15, issue.1, pp.10-17, 2003. ,
An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients, Urology, vol.68, issue.2, pp.386-91, 2006. ,
,
, Société Française d'Angéiologie, 2017.
Daily application of alprostadil topical cream (Vitaros) does not impact vaginal pH, flora, or histology in female cynomolgus monkeys, Int J Toxicol, vol.34, issue.1, pp.11-16, 2015. ,
Treatments for erectile dysfunction in spinal cord patients: alternatives to phosphodiesterase type 5 inhibitors? A review study, Spinal Cord, vol.53, issue.12, pp.849-54, 2015. ,
,
, Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury, Spinal Cord, vol.52, issue.1, pp.70-76, 2014.
Phase 2 trial of sustained-release fampridine in chronic spinal cord injury, Spinal Cord, vol.45, issue.2, pp.158-68, 2006. ,
Apomorphine sublingual as primary or secondary treatment for erectile dysfunction in patients with spinal cord injury ,
, BJU Int, vol.93, issue.1, pp.100-104, 2004.
The resurgence of the vacuum erection device (VED) for treatment of erectile dysfunction, J Sex Med, vol.10, issue.4, pp.1124-1159, 2013. ,
Penile Prosthetic Surgery in Neurologically Impaired Patients: Long-Term Followup, The Journal of Urology ,
DOI : 10.1016/s0022-5347(05)00344-7
Usefulness of a malleable penile prosthesis in patients with a spinal cord injury, Int J Urol, vol.15, issue.10, pp.919-942, 2008. ,
Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury, Spinal Cord, vol.49, issue.5, pp.629-665, 2011. ,
DOI : 10.1038/sc.2010.176
URL : http://www.nature.com/sc/journal/v49/n5/pdf/sc2010176a.pdf
,
, Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function, J Sex Med, vol.5, issue.9, pp.2135-2175, 2008.
Neurostimulation des racines sacrées antérieures avec rhizotomies postérieures (technique de Brindley), Neurochirurgie, vol.49, issue.2-3, pp.383-94, 2003. ,
Technique de Brindley et neurovessies des lésions médullaires ,
, IRME / Institut pour le Recherche sur la Moelle epinière et l'Encéphale, 2007.
Sacral anterior root stimulation for bladder control: clinical results, Arch Physiol Biochem, vol.107, issue.3, pp.248-56, 1999. ,
, Bibliographie-95
Sexuality of paraplegic male patient and stimulation according to G.S. Brindley's technique. Sexualité, fertilité et handicap ,
, Problèmes en Médecine de Rééducation 31